<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">8546909</article-id><article-id pub-id-type="pmc">2074303</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Matsui</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fukuoka</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Takada</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kusunoki</surname><given-names>Y.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yana</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tamura</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yoshida</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iida</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hirashima</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tsukada</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ushijima</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Miyawaki</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Masuda</surname><given-names>N.</given-names></name></contrib></contrib-group><aff>Department of Internal Medicine, Osaka Prefectural Habikino Hospital, Japan.</aff><pub-date pub-type="ppub"><month>1</month><year>1996</year></pub-date><volume>73</volume><issue>2</issue><fpage>217</fpage><lpage>221</lpage><abstract><p>Despite recent advances in control of acute emesis following cisplatin-based chemotherapy regimens, delayed emesis remains a significant cause of treatment-related morbidity and factors associated with delayed emesis have not yet been evaluated. A prospective randomised trial was conducted to compare the efficacy and toxicity of granisetron, dexamethasone plus prochlorperazine with granisetron alone in controlling cisplatin-induced delayed emesis and to identify the important factors that influence its occurrence and severity. Seventy cisplatin-naive patients with inoperable solid tumors participated in the trial. Patients who received 80 mg m-2 or 100 mg m-2 of cisplatin were randomly assigned to receive either granisetron 40 micrograms kg-1 intravenously (i.v.) on day 1, dexamethasone 20 mg i.v. on days 2 and 3 and prochlorperazine 5 mg orally thrice daily on days 1-5 or granisetron 40 micrograms kg-1 i.v. on day 1 alone. There was no difference in their acute antiemetic efficacy. A combination regimen was more effective than granisetron alone in preventing delayed symptoms, with superior rates of complete plus major responses of 77% vs 51% (P = 0.0460). Treatment arm was the only determinant factor for the occurrence of delayed emesis (P = 0.0101).</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00030-0089.tif" xlink:title="scanned-page" xlink:role="217" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00030-0090.tif" xlink:title="scanned-page" xlink:role="218" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00030-0091.tif" xlink:title="scanned-page" xlink:role="219" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00030-0092.tif" xlink:title="scanned-page" xlink:role="220" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00030-0093.tif" xlink:title="scanned-page" xlink:role="221" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

